Treatment of von Willebrand's Disease
- 1 August 1991
- journal article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 66 (8) , 841-846
- https://doi.org/10.1016/s0025-6196(12)61203-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Nasal Spray Desmopressin (DDAVP) for Mild Hemophilia A and von Willebrand DiseaseAnnals of Internal Medicine, 1991
- Immunoadsorption for coagulation factor inhibitorsTransfusion, 1991
- Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type IAnnals of Hematology, 1990
- Pharmacology and Pharmacokinetics of Desmopressin in Haemostatic DisordersClinical Drug Investigation, 1990
- DDAVP shortens the prolonged bleeding times of patients with severe von Willebrand disease treated with cryoprecipitate. Evidence for a mechanism of action independent of released von Willebrand factorBlood, 1989
- Use of a High‐Purity Factor VIII Concentrate (Hemate P) in von Willebrand's Disease1Vox Sanguinis, 1989
- Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders [see comments]Blood, 1988
- Von Willebrand's DiseaseClinics in Haematology, 1983
- Immunologic differentiation of classic hemophilia (factor VIII deficiency) and von Willebrand's diseaseJournal of Clinical Investigation, 1971
- Platelet Adhesiveness in von Willebrand’s DiseaseAmerican Journal of Clinical Pathology, 1969